AGIJ NEWS July 12, 2012 15:45 ET Axia Group (AGIJ:PK)

New Post Public Reply Private Reply Replies (1) Message Board
vulken17

AGIJ NEWS

July 12, 2012 15:45 ET

Axia Group (AGIJ K) Collagenna Skin Care in Merger Talks

OTTAWA, ONTARIO--(Marketwire - July 12, 2012) - Axia Group (PINKSHEETS:AGIJ)( http://www.axiagroup.com/ ) Collagenna Skin Care Products/Melem Secret has commenced merger talks with an existing Vitamin/Supplement E-Commerce Super Store. The management is of the opinion that this is a material event that requires a public release.

Michael Arnkvarn, AGIJ CEO states 'We have commenced discussions with an E-Commerce Super Store as part of our strategy to increase revenues and augment our US presence. I personally have a lot of knowledge about the supplement and vitamin industry and we would plan to offer our own product line as well as brand names on the site. Properly marketed, this site can generate important revenues and a good mix of our products along with brand names will increase sales margins. This is the first step of several which we plan to complete by the end of the third quarter.'

Collagenna Skin Care Products specializes in Anti-aging products with an emphasis on Collagen stimulation both topically and internally. The company sells its products mainly through specialized skin care clinics through its every expanding network of distribution partners.

More details and updates will be provided via opt in emails to our subscribers at  www.bit.ly/dcPzS0 . More news will follow shortly and on a timely basis.

Safe Harbor Statement

Information in this news release may contain statements about future expectations, plans, prospects or performance of Axia Group Inc., that constitute forward-looking statements for purposes of the Safe Harbor Provisions under the Private Securities Litigation Reform Act of 1995. The words or phrases "can be," "expects," "may affect," "believed," "estimate," "project" and similar words and phrases are intended to identify such forward-looking statements. Axia Group Inc. cautions you that any forward-looking information provided by or on behalf of Axia Group Inc. is not a guarantee of future performance. None of the information in this press release constitutes or is intended as an offer to sell securities or investment advice of any kind. Axia Group Inc.'s actual results may differ materially from those anticipated in such forward-looking statements as a result of various important factors, some of which are beyond Axia Group Inc.'s control. In addition to those discussed in Axia Group Inc.'s press releases, public filings, and statements by Axia Group Inc.'s management, including, but not limited to, Axia Group Inc.'s estimate of the sufficiency of its existing capital resources, Axia Group Inc.'s ability to raise additional capital to fund future operations, Axia Group Inc.'s ability to repay its existing indebtedness, the uncertainties involved in estimating market opportunities, and in identifying contracts which match Axia Group Inc.'s capability to be awarded contracts. All such forward-looking statements are current only as of the date on which such statements were made. Axia Group Inc. does not undertake any obligation to publicly update any forward-looking statement to reflect events or circumstances after the date on which any such statement is made or to reflect the occurrence of unanticipated events.

SOURCE: Axia Group Inc.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 5

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 14

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading

Top 5 Most Recently Viewed Articles

SAP Launches Sovereign Cloud Solution in Canada for Businesses

Updated Category News Views 365

SAP Enhances Data Security with New Cloud Solutions SAP SE shares are experiencing a positive trend in premarket trading. Recently, SAP Canada introduced its innovative SAP Sovereign Cloud capabilities, which are designed to address the increasing demand from organizations for data sovereignty, robust security, and regulatory compliance. This pioneering solution enables...

Continue Reading
Corbus Pharma's Stock Drops 60%: Analysts Recommend Buying Now

Updated Category News Views 92

Corbus Pharmaceuticals Sees Significant Stock Drop Amid Market Responses Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) has recently faced a dramatic decline in its stock, plummeting by an alarming 60%. However, analysts are encouraging investors to view this as a potential buying opportunity. Firms like H.C. Wainwright and Oppenheimer have reaffirmed their buy...

Continue Reading
Manatt Welcomes New Partner with Extensive Investment Expertise

Updated Category News Views 139

Manatt's Strategic Growth in Corporate Practice Manatt, Phelps & Phillips, LLP is making waves in the corporate legal landscape with its recent addition of Peter Tsirigotis, a seasoned investment funds partner. This move reflects the firm's commitment to expanding its financial services and corporate capabilities. Based in Washington, D.C., Tsirigotis brings a wealth of...

Continue Reading
Performance Share Units Vesting: ISS A/S Updates Details

Updated Category News Views 216

Performance Share Units Vesting Announcement ISS A/S is proud to announce the significant milestone concerning its long-term incentive program (LTIP). As part of this initiative, a number of Performance Share Units (PSUs) have recently vested, leading to the delivery of ISS shares to key personnel within the company. This process, which emphasizes the company's commitment...

Continue Reading
Omnicom Boosts Dividend: New Shareholder Benefit Unveiled

Updated Category News Views 196

Omnicom Boosts Dividend for Shareholders Omnicom, a renowned leader in marketing and sales, has officially announced an increase in its quarterly dividend to $0.80 per share. This enhancement reflects a significant increase in the company's commitment to its shareholders, offering both immediate rewards and a long-term strategy for growth. Dividend Increase Overview The...

Continue Reading